Transforming growth factor–β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycans

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 309, Issue 3, 2015, Pages G171-G180

  Namachivayam, Kopperuncholan ^a,b   Coffing, Hayley P ^a   Sankaranarayanan, Nehru Viji ^c   Jin, Yingzi ^c   Mohankumar, Krishnan ^a,b   Frost, Brandy L ^d   Blanco, Cynthia L ^e   Patel, Aloka L ^f   Meier, Paula P ^f   Garzon, Steven A ^a   Desai, Umesh R ^c   Maheshwari, Akhil ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast milk; Chondroitinase; Inflammation; Necrotizing enterocolitis; TGF 2

Indexed keywords

ALKALINE PHOSPHATASE; BIGLYCAN; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; DECORIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; N ACETYLGALACTOSAMINE 4 SULFATASE; PHOSPHACAN; PROTEOCHONDROITIN SULFATE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BREAST MILK; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; FEEDING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; LUCIFERASE ASSAY; MACROPHAGE; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NEWBORN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; ANIMAL; CELL LINE; ENTEROCOLITIS, NECROTIZING; ENZYMOLOGY; INTESTINE; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE; CHONDROITIN SULFATE PROTEOGLYCANS; CHONDROITINASES AND CHONDROITIN LYASES; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; INTESTINES; MACROPHAGE ACTIVATION; MICE; MILK, HUMAN; NF-KAPPA B; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84938632159     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00126.2015     Document Type: Article

References (37)

1. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38: 1549–1563, 1990.
2. Brown DC, Vogel KG. Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. Matrix 9: 468–478, 1989.
3. Brunelle JL, Green R. Coomassie blue staining. Methods Enzymol 541: 161–167, 2014.
4. Coppa GV, Gabrielli O, Buzzega D, Zampini L, Galeazzi T, Maccari F, Bertino E, Volpi N. Composition and structure elucidation of human milk glycosaminoglycans. Glycobiology 21: 295–303, 2011.
5. Coppa GV, Gabrielli O, Zampini L, Galeazzi T, Maccari F, Buzzega D, Galeotti F, Bertino E, Volpi N. Glycosaminoglycan content in term and preterm milk during the first month of lactation. Neonatology 101: 74–76, 2012.
6. Cowman MK, Slahetka MF, Hittner DM, Kim J, Forino M, Gadelrab G. Polyacrylamide-gel electrophoresis and alcian blue staining of sulphated glycosaminoglycan oligosaccharides. Biochem J 221: 707–716, 1984.
7. Franke WW, Heid HW, Grund C, Winter S, Freudenstein C, Schmid E, Jarasch ED, Keenan TW. Antibodies to the major insoluble milk fat globule membrane-associated protein: specific location in apical regions of lactating epithelial cells. J Cell Biol 89: 485–494, 1981.
8. Hawkes JS, Bryan DL, James MJ, Gibson RA. Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res 46: 194–199, 1999.
9. Henry BL, Connell J, Liang A, Krishnasamy C, Desai UR. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function. J Biol Chem 284: 20897–20908, 2009.
10. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302 (Pt 2): 527–534, 1994.
11. Horiguchi M, Ota M, Rifkin DB. Matrix control of transforming growth factor-beta function. J Biochem 152: 321–329, 2012.
12. Kalliomaki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol 104: 1251–1257, 1999.
13. Karamanos NK, Syrokou A, Vanky P, Nurminen M, Hjerpe A. Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal Biochem 221: 189–199, 1994.
14. Kitamikado M, Lee YZ. Chondroitinase-producing bacteria in natural habitats. Appl Microbiol 29: 414–421, 1975.
15. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11: 725–732, 2001.
16. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280: L1327–L1334, 2001.
17. Laskowski RA, Swindells MB. LigPlot_: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51: 2778–2786, 2011.
18. Lebman DA, Edmiston JS. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1: 1297–1304, 1999.
19. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-beta 1 null mice. Science 264: 1936–1938, 1994.
20. Locci P, Marinucci L, Lilli C, Martinese D, Becchetti E. Transforming growth factor beta 1-hyaluronic acid interaction. Cell Tissue Res 281: 317–324, 1995.
21. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 272: 18000–18006, 1997.
22. Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, Athar M, Shimamura M, Bhandari V, Aprahamian C, Dimmitt RA, Serra R, Ohls RK. TGF-beta(2) Suppresses Macrophage Cytokine Production and Mucosal Inflammatory Responses in the Developing Intestine. Gastroenterology 140: 242–253, 2011.
23. McPherson RJ, Wagner CL. TGFβ2 distribution in aqueous and fat compartments of human milk. Pediatr Res 41: 85-85, 1997.
24. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J. Biospecimen reporting for improved study quality (BRISQ). J Proteome Res 10: 3429–3438, 2011.
25. Mulloy B. Progress in the structural biology of chondroitin sulfate. Adv Pharmacol 53: 49–67, 2006.
26. Namachivayam K, Blanco CL, Frost BL, Reeves AA, Jagadeeswaran R, MohanKumar K, Safarulla A, Mandal P, Garzon SA, Raj JU, Maheshwari A. Preterm human milk contains a large pool of latent TGF-beta, which can be activated by exogenous neuraminidase. Am J Physiol Gastrointest Liver Physiol 304: G1055–G1065, 2013.
27. Namachivayam K, Blanco CL, MohanKumar K, Jagadeeswaran R, Vasquez M, McGill-Vargas L, Garzon SA, Jain SK, Gill RK, Freitag NE, Weitkamp JH, Seidner SR, Maheshwari A. Smad7 inhibits autocrine expression of TGF-beta2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 304: G167–G180, 2013.
28. Patthy L. Detecting homology of distantly related proteins with consensus sequences. J Mol Biol 198: 567–577, 1987.
29. Raghuraman A, Mosier PD, Desai UR. Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem 49: 3553–3562, 2006.
30. Raghuraman A, Mosier PD, Desai UR. Understanding dermatan sulfateheparin cofactor II interaction through virtual library screening. ACS Med Chem Lett 1: 281–285, 2010.
31. Rautava S, Nanthakumar NN, Dubert-Ferrandon A, Lu L, Rautava J, Walker WA. Breast milk-transforming growth factor-beta(2) specifically attenuates IL-1beta-induced inflammatory responses in the immature human intestine via an SMAD6- and ERK-dependent mechanism. Neonatology 99: 192–201, 2011.
32. Reeves AA, Johnson MC, Vasquez MM, Maheshwari A, Blanco CL. TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk. Breastfeed Med 8: 496–502, 2013.
33. Shaik SS, Soltau TD, Chaturvedi G, Totapally B, Hagood JS, Andrews WW, Athar M, Voitenok NN, Killingsworth CR, Patel RP, Fallon MB, Maheshwari A. Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinasep38{beta} MAPK-NF-{kappa}B pathway. J Biol Chem 284: 5945–5955, 2009.
34. Takeuchi Y, Kodama Y, Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem 269: 32634–32638, 1994.
35. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223: 587–597, 1984.
36. Wu Z, Horgan CE, Carr O, Owens RT, Iozzo RV, Lechner BE. Biglycan and decorin differentially regulate signaling in the fetal membranes. Matrix Biol 2013.
37. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281–284, 1990.